Astrocytes in Parkinson's Disease neurodegeneration refers to the role of astrocytes in the pathogenesis and progression of Parkinson's disease. Astrocytes, the most abundant glial cells in the brain, provide metabolic support, regulate synaptic function, and respond to neural injury. In PD, astrocytes undergo reactive changes that can be both protective and detrimental to dopaminergic neurons.
Astrocytes In Parkinson'S Disease Neurodegeneration is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Astrocytes are critical supporting cells in the brain that maintain neuronal health, but they also play complex roles in Parkinson's disease pathogenesis and progression.
- Metabolic support: Lactate supply to neurons
- Ion homeostasis: Potassium buffering
- Neurotransmitter recycling: Glutamate uptake
- Blood-brain barrier maintenance
- Synaptic support: Formation and function
In response to CNS injury:
- Proliferation
- Hypertrophy
- Glial fibrillary acidic protein (GFAP) upregulation
- Release of signaling molecules
- Early morphological changes
- Altered glutamate transport
- Reduced trophic support
- Involvement in alpha-synuclein clearance
Astrocytes can:
- Internalize extracellular alpha-synuclein
- Propagate aggregates between cells
- Fail to efficiently clear pathological species
- Become inflammatory themselves
- Reduced EAAT1/EAAT2 expression
- Impaired glutamate uptake
- Excitotoxicity
- Contributes to neurodegeneration
- Pro-inflammatory cytokine release
- Chemokine production
- Microglial activation priming
- Chronic inflammatory state
- Complex I impairment shared with neurons
- ROS production
- Energy failure
- Spreading to neurons
- Reduced GDNF release
- Reduced BDNF
- Diminished neuroprotection
- Impaired repair capacity
Pro-inflammatory phenotype:
- Induced by microglia
- Neurotoxic
- Upregulated complement proteins
- Lost supportive functions
Potentially protective:
- Upregulated neurotrophic factors
- Tissue repair functions
- Synapse support
- Anti-inflammatory profile
- Anti-inflammatory: Reduce A1 polarization
- Enhance clearance: Improve alpha-synuclein handling
- Trophic support: GDNF delivery
- Glutamate modulation: Restore uptake
- Astrocyte transplantation
- Gene therapy for GFAP
- Modulation of astrocyte-neuron interactions
The study of Astrocytes In Parkinson'S Disease Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Maragakis & Rothstein, Astrocytes in neurodegenerative disease (2006)
- Booth et al., Astrocytes in PD (2017)
- Liddelow & Barres, Reactive astrocytes (2017)
- Zhang et al., Astrocyte alpha-synuclein in PD (2020)